UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Link zum Volltext

Verfügbarkeit prüfen

Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor

Blood, 2010-02, Vol.115 (5), p.1037-1048

2010

Link zum Volltext

Verfügbarkeit prüfen

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Blood, 2007-11, Vol.110 (10), p.3735-3743

2007

Link zum Volltext

Verfügbarkeit prüfen

Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor?

Leukemia & lymphoma, 2022-12, Vol.63 (13), p.3175-3180

2022

Link zum Volltext

Verfügbarkeit prüfen

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia

Cancer, 2017-11, Vol.123 (22), p.4403-4410

2017

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Blood, 2003-04, Vol.101 (8), p.2983-2989

2003

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators

Shock (Augusta, Ga.), 2018-06, Vol.49 (6), p.641-648

2018

Link zum Volltext

Verfügbarkeit prüfen

From 1 to 2 mutated JAK2: the road from ET to PV

Blood, 2006-10, Vol.108 (7), p.2140-2141

2006

Link zum Volltext

Verfügbarkeit prüfen

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

Blood, 2008-08, Vol.112 (4), p.1402-1412

2008

Link zum Volltext

Verfügbarkeit prüfen

High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice

Blood, 1997-12, Vol.90 (11), p.4369-4383

1997

Link zum Volltext

Verfügbarkeit prüfen

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets

Blood, 2010-07, Vol.116 (3), p.437-445

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Leukemia, 2023-08, Vol.37 (8), p.1741-1744

2023

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement

British journal of haematology, 2022-02, Vol.196 (3), p.676-680

2022

Link zum Volltext

Verfügbarkeit prüfen

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis

Blood, 2007-01, Vol.109 (1), p.71-77

2007

Link zum Volltext

Verfügbarkeit prüfen

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Blood cancer journal (New York), 2018-10, Vol.8 (10), p.94-6, Article 94

2018

Link zum Volltext

Verfügbarkeit prüfen

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses

Haematologica (Roma), 2020-03, Vol.105 (3), p.e95

2020

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors

Blood, 2002-10, Vol.100 (8), p.2932-2940

2002

Link zum Volltext

Verfügbarkeit prüfen

Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition

Blood advances, 2022-05, Vol.6 (9), p.2813-2823

2022

Link zum Volltext

Verfügbarkeit prüfen

Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment

European journal of haematology, 2016-01, Vol.96 (1), p.19-26

2016

Link zum Volltext

Verfügbarkeit prüfen

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Blood, 2008-09, Vol.112 (6), p.2429-2438

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(46)
Humans
(39)
Biological And Medical Sciences
(17)
Hematologic And Hematopoietic Diseases
(17)
Medical Sciences
(17)
Male
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Myeloproliferative Disorders - Genetics
(14)
Female
(13)
Mutation
(13)
Animals
(11)
Biochemistry
(11)
Cell Biology
(11)
Immunology
(11)
Janus Kinase 2 - Genetics
(11)
Mice
(11)
Adult
(9)
Middle Aged
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study)

Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Expression level and differential JAK2-V617F–binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms

Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study

Calcific tendinopathy: an unexpected side effect of tyrosine kinase inhibitor?

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia

Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO

Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators

From 1 to 2 mutated JAK2: the road from ET to PV

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice

miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets

Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors

Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition

Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

Aktive Filter

Suchergebnisse filtern